Access cutting-edge hiv-1 treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Access hiv-1 specialists in Memphis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv-1 treatment provided free
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this hiv-1 clinical trial in Memphis, TN
If you're searching for hiv-1 treatment options in Memphis, TN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv-1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.